The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment response among patients with multiple myeloma initiating daratumumab across different lines of therapy: A real-world chart review study.
 
Shebli Atrash
Honoraria - Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Speakers' Bureau - Amgen; GlaxoSmithKline; Janssen; Karyopharm Therapeutics
 
Philippe Thompson-Leduc
Employment - Analysis Group
Research Funding - Janssen Scientific Affairs (Inst)
 
Ming-Hui Tai
Employment - Janssen Scientific Affairs
 
Shuchita Kaila
Employment - Janssen Scientific Affairs
 
Kathleen Gray
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Johnson & Johnson
 
Isabelle Ghelerter
Employment - Analysis Group
Research Funding - Janssen Scientific Affairs (Inst)
 
Marie-Hélène Lafeuille
Employment - Analysis Group
Research Funding - Janssen Scientific Affairs (Inst)
 
Patrick Lefebvre
Employment - Analysis Group
Research Funding - Janssen Scientific Affairs (Inst)
 
Adriana C. Rossi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen